Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (USA)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Arterial Disease Suppliers Serving USA
80 companies found
based inDurham, NORTH CAROLINA (USA)
Tryton Medical is a leading developer of novel stent systems for the treatment of bifurcation lesions. The co-founders of the company, Aaron V. Kaplan M.D. and H. Richard Davis, recognized an unmet need in coronary artery disease treatment. ...
based inSan Marcos, CALIFORNIA (USA)
ACI Medical, LLC is a biomedical engineering firm engaged in the research, development, manufacture and sale of therapeutic products and technologies for individuals with varying degrees of limb- and life-threatening vascular conditions. With more ...
ArtAssist is a home-use medical treatment designed to increase blood flow without surgery so that wounds can heal and patients can keep their ...
based inMidlothian, VIRGINIA (USA)
G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
All drugs targeting cardiovascular disease currently on the market work by lowering cholesterol levels. G3T identified and genetically validated an entirely novel biological mechanism and potential drug target that treats both cardiovascular ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
ALDURAZYME (laronidase) is indicated for patients with Hurler and Hurler-Scheie forms of mucopolysaccharidosis I (MPS I) and for patients with the Scheie form who have moderate to severe symptoms. The risks and benefits of treating mildly affected ...
based inHorsholm, DENMARK
At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...
based inSalt Lake City,, UTAH (USA)
Alucent Biomedical is a privately held biomedical company focused on our vision to transform the way vascular disease is treated. We are focused on using advanced technology to harness the body’s own natural physiologic processes and structures. ...
The Alucent NVS Vessel Restoration System is designed to create a natural, stent-like scaffold using the body’s own tissue and processes. An all-in-one, integrated procedural system, Alucent NVS combines standard angioplasty techniques with a ...
based inWolfratshausen, GERMANY
Since ELCAT was founded in 1981, it develops, produced and markets electronic devices for medical technology. Our core competences are in the doppler and plethysmograph product fields. We are a medium-sized company that employs a staff of about 20 ...
the all-round talent with memory function for your bidirectional Doppler sonography, very good sensitivity, Ultrasound Pen Probes, interchangeable ultrasonic modules, Storage of Exams, investigation programs, Voice memo recording, Battery operation ...
based inSan Jose, CALIFORNIA (USA)
LimFlow was founded with the deep belief that more could be done for the millions of patients worldwide suffering from the most severe form of peripheral artery disease — Chronic Limb-Threatening Ischemia (CLTI) — and who are facing the prospect of ...
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is ...
based inBonn, GERMANY
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The ...
The LEGFLOW balloon drug coating quality is a major step beyond contemporary first and second generation DCB ...
based inAliso Viejo, CALIFORNIA (USA)
In 1997 MicroVention was founded and incorporated in a small facility in Southern California. We are a worldwide community of over 2000 engineers, chemists, marketers, manufacturers, researchers, and innovators who share the same ethos - creating ...
based inSanta Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve ...
based inLatham, NEW YORK (USA)
The Auryon Atherectomy System represents a technological breakthrough among medical devices used in procedures to treat Peripheral Arterial Disease (PAD). The Auryon Atherectomy System is FDA cleared for use in the treatment, including atherectomy, ...
based inMont-Saint-Guibert, BELGIUM
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution platform is based on the Genio® system, a CE-Mark validated, ...
Genio is the disruptive sleep apnea solution for patients who suffer from moderate to severe Obstructive Sleep Apnea or OSA. Genio is the world’s first and unique battery-free, leadless, full body MR conditional and minimally invasive ...
based inWuxi, CHINA
CHISON Medical Technologies Co., LTD has emerged as World’s leading Diagnostic Ultrasound manufacturer since its inception in 1996. In the journey of constant development and revolution in technologies, CHISON has set its foot independently with ...
A revolutionary invention with everything you can imagine makes you more ...
based inSan Francisco, CAMBODIA
Verana Health is a digital health company that delivers quality drug lifecycle, medical practice, and medical society insights from an exclusive real-world data network of more than 20,000 healthcare providers. Our specialty medical society partners ...
based inMontreal, QUEBEC (CANADA)
QXMedical was founded in 2007 in Montreal, Canada on the principle of providing uncompromised value and quality in underserved high-growth segments of the medical device market. Today, the company is known for its innovative solutions for complex, ...
based inMadison, WISCONSIN (USA)
Vascular diseases afflict hundreds of millions of people worldwide. Many patients do not respond to standard treatments. We are developing regenerative medicines to address these unmet needs. Vascugen is dedicated to revolutionizing the standard of ...
based inJarfälla, SWEDEN
Perimed AB is a Swedish company, founded in 1981 and headquartered just outside Stockholm, that develops, manufactures and markets state-of-the-art diagnostic equipment to assess microcirculation and peripheral perfusion as well as peripheral ...
Our sensitive laser Doppler technique provides accurate toe pressure measurements. By adding the SPP technique, a more comprehensive wound healing assessment can be obtained. All pressure tests are easy and fast to perform thanks to our ...
based inLos Gatos, CALIFORNIA (USA)
Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all ...
Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic ...
based inRouen, FRANCE
Founded in 2009 by Philippe Bencteux, MD, Robocath designs, develops and commercializes robotic solutions to treat cardiovascular diseases. As an active player in the evolving medical robotic industry, these innovative solutions aim to make medical ...
Innovation is at the heart of Robocath’s strategy, making R-One™ a unique solution, protected by over 60 international ...
